Charles Semba (仙波), Md Email and Phone Number
Charles Semba (仙波), Md work email
- Valid
- Valid
- Valid
- Valid
- Valid
Charles Semba (仙波), Md personal email
Charles Semba (仙波), Md phone numbers
+20 years in therapeutic product development in public (Genentech, Shire/Takeda) and private companies (SARcode Biosciences, ForSight VISION5, Graybug Vision); small molecules, biologics, sustained-release, drug delivery; ocular surface, glaucoma, retinal diseases and collagen-based medical devices..
Eluminex Biosciences Limited
View-
Chief Medical OfficerEluminex Biosciences Limited Jun 2020 - PresentSuzhou, CnEluminex Biosciences is a privately-held clinical-stage biotechnology company focused on both global and regional development and commercialization of innovative therapeutics to fulfill unmet medical needs in the treatment and management of vision-threatening diseases. -
Board MemberDiamedica Therapeutics Inc. Jul 2021 - PresentMinneapolis, Mn, UsDiaMedica Therapeutics is a clinical-stage biopharmaceutical company committed to changing the treatment paradigm for acute ischemic stroke (AIS) and chronic kidney disease (CKD). DiaMedica’s lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality for the treatment of acute ischemic stroke and chronic kidney disease. -
Adjunct Professor - Vascular And Interventional RadiologyStanford University School Of Medicine 1992 - PresentPalo Alto, Ca, UsDevelopment of minimally invasive endovascular treatments for venous disease and complex aortic dissection and thoracic aneurysm repair. Fellowship Program Director. -
Chief Medical OfficerGraybug Vision, Inc. Jun 2016 - Mar 2020Graybug is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve.
-
Chief Medical OfficerForsight Vision5, Inc. Jun 2014 - Jun 2016(Acquired by Allergan for $95M plus milestones) Sustained-delivery of bimatoprost using a novel ocular insert for the treatment of glaucoma/ocular hypertension. Phase 1, 2 development programs and Phase 3 planning. Development of fixed combination (bimatoprost/timolol) ocular insert for glaucoma/ocular hypertension. -
Vice President - Clinical Medicine (Ophthalmology)Shire Apr 2013 - Jun 2014Tokyo, Jp, JpGlobal clinical development lead for Xiidra (lifitegrast ophthalmic solution) for dry eye disease (acquired from SARcode Bioscience). Approved by FDA July 2016. -
Chief Medical OfficerSarcode Bioscience, Inc. Nov 2007 - Apr 2013Brisbane, California, Us(Acquired by Shire for $160M plus future milestones). Development of lifitegrast ophthalmic solution for dry eye disease. IND filing through NDA. -
Senior Group Director - Division Of Tissue Growth And RepairGenentech 2000 - 2007South San Francisco, California, UsClinical development team leader for ranibizumab (Lucentis), Phase 1b through BLA-filing and FDA approval (June 2006); neovascular age-related macular degeneration(AMD), diabetic macular edema (DME), retinal vein occlusion (RVO). Cardiovascular medicine - clinical lead sBLA TNKase (tenecteplase) approval - acute myocardial infarction, sBLA Activase approval (alteplase) - acute ischemic stroke, sBLA approval CathFlo Activase (alteplase) - restoration of function to central venous access devices.
Charles Semba (仙波), Md Skills
Charles Semba (仙波), Md Education Details
-
Uc San DiegoDiagnostic Radiology -
Miami Cardiac & Vascular InstituteVascular And Interventional Radiology -
University Of Minnesota Medical SchoolMd -
Carleton CollegeChemistry
Frequently Asked Questions about Charles Semba (仙波), Md
What company does Charles Semba (仙波), Md work for?
Charles Semba (仙波), Md works for Eluminex Biosciences Limited
What is Charles Semba (仙波), Md's role at the current company?
Charles Semba (仙波), Md's current role is Chief Medical Officer and Board Member. Developing global innovative therapeutics for dermal aesthetics and vision-threatening diseases. Look better. See better..
What is Charles Semba (仙波), Md's email address?
Charles Semba (仙波), Md's email address is cp****@****ode.com
What is Charles Semba (仙波), Md's direct phone number?
Charles Semba (仙波), Md's direct phone number is +165064*****
What schools did Charles Semba (仙波), Md attend?
Charles Semba (仙波), Md attended Uc San Diego, Miami Cardiac & Vascular Institute, University Of Minnesota Medical School, Carleton College.
What are some of Charles Semba (仙波), Md's interests?
Charles Semba (仙波), Md has interest in Christianity, Kids, Cooking, Electronics, Outdoors, Home Improvement, Donor, Shooting, Gourmet Cooking, Sports.
What skills is Charles Semba (仙波), Md known for?
Charles Semba (仙波), Md has skills like Biotechnology, Clinical Trials, Drug Development, Clinical Development, Pharmaceutical Industry, Immunology, Biopharmaceuticals, Medical Devices, Clinical Research, Medicine, Ophthalmology, Life Sciences.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial